ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors

View/Open
Volume
32
DOI
10.1200/jco.2014.32.15_suppl.2531
Issue
15
ISSN
0732-183X
Metadata
Show full item record
Authors
Ghazaly, EA; Rizzuto, I; Gabra, H; Habib, NA; Leonard, RCF; Wasan, H; McGuigan, C; Blagden, SP
URI
http://meetinglibrary.asco.org/content/149421-156
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11296
Collections
Copyright statements
American Society of Clinical Oncology